Alzheimer’s disease has no single cause. It results from a combination of abnormal protein buildup in the brain, genetic susceptibility, chronic inflammation, and lifestyle and metabolic factors that interact over decades. For most people, the disease emerges from this web of overlapping triggers rather than one clear starting point.
That answer might feel unsatisfying if you were hoping for a simple explanation, but it reflects where the science actually stands. The dominant theory for the past 30 years has centered on a protein called beta-amyloid, and while that protein clearly plays a role, recent research shows it’s far from the whole story.
The Amyloid and Tau Protein Buildup
The most visible hallmarks of Alzheimer’s are two types of abnormal protein deposits in the brain. The first involves beta-amyloid, a fragment produced when a larger protein (amyloid precursor protein) gets broken down. Beta-amyloid occurs naturally, but in Alzheimer’s, an especially toxic form called beta-amyloid 42 accumulates at abnormal levels and clumps together into plaques between brain cells. These plaques disrupt the signaling that neurons rely on to communicate with each other.
The second protein involved is tau. In a healthy brain, tau helps stabilize the internal scaffolding of neurons, the structures that transport nutrients from one part of the cell to another. In Alzheimer’s, tau undergoes chemical changes: it gets excessively modified, folds into abnormal shapes, and aggregates into tangled fibers inside neurons. These tangles choke off the cell’s internal transport system. Starved of nutrients and unable to communicate normally, affected neurons eventually die.
The long-standing “amyloid cascade hypothesis” proposes a neat sequence: amyloid plaques form first, triggering tau tangles, which cause neurodegeneration, which produces cognitive decline. This model is the foundation of the most recent diagnostic criteria from the Alzheimer’s Association. But a 2024 study published in Neurology tested this sequence against real patient data and found that only about one-third of people diagnosed with Alzheimer’s actually followed that predicted progression. In roughly two-thirds of cases, the clinical symptoms couldn’t be fully explained by the amyloid cascade alone. Other factors were clearly modulating the disease.
Genetics: The Strongest Known Risk Factor
The gene with the biggest influence on typical, late-onset Alzheimer’s is called APOE. Everyone carries two copies of this gene, and one variant, APOE-e4, substantially raises risk. Carrying one copy of APOE-e4 doubles or triples your likelihood of developing Alzheimer’s. Carrying two copies makes you 8 to 12 times more likely to develop it. That said, plenty of people with APOE-e4 never get Alzheimer’s, and many people without it do. It shifts the odds; it doesn’t determine the outcome.
A rarer form of the disease, early-onset Alzheimer’s, strikes before age 65 and is more directly genetic. Mutations in a gene called PSEN1 are the most common cause, responsible for up to 70% of early-onset cases. These mutations produce a defective protein that interferes with the molecular machinery responsible for processing amyloid precursor protein. The result is overproduction of the toxic, longer form of beta-amyloid. Mutations in two other genes, APP and PSEN2, account for additional cases. Unlike late-onset Alzheimer’s, these inherited mutations virtually guarantee disease development, though they account for a small fraction of all Alzheimer’s cases overall.
The Brain’s Immune System Turns Harmful
The brain has its own immune cells called microglia. Under normal conditions, they patrol for damage, clear debris, and help maintain healthy connections between neurons. In Alzheimer’s, microglia initially respond to amyloid buildup by trying to remove it. But when the buildup is chronic and persistent, microglia shift into a state of sustained activation that becomes destructive.
Chronically activated microglia release inflammatory signals that damage surrounding tissue and directly contribute to synapse loss. Research has shown that microglia, working with part of the immune system called complement, can physically strip away synapses, the connection points between neurons. This synapse pruning begins before amyloid plaques are even visible, suggesting inflammation may be an early driver of the disease rather than just a consequence of it. Microglia also influence neighboring support cells called astrocytes, pushing them into a toxic state that reduces their ability to nourish neurons and clear waste. The result is a self-reinforcing cycle: protein buildup triggers inflammation, inflammation worsens protein buildup, and neurons are caught in the crossfire.
Metabolic Health and Blood Sugar
The connection between metabolic dysfunction and Alzheimer’s is strong enough that some researchers have informally called Alzheimer’s “type 3 diabetes.” Insulin does far more in the brain than most people realize. It supports the energy supply neurons need to function, promotes the formation and maintenance of synaptic connections, and helps regulate neurotransmitters. Critically, insulin also influences the clearance of beta-amyloid and the chemical modification of tau, the two proteins at the heart of Alzheimer’s pathology.
When the brain becomes resistant to insulin, all of these protective functions weaken. Amyloid clearance slows. Tau gets modified in harmful ways. Vascular function declines because insulin also helps regulate blood flow, lipid metabolism, and inflammation in the brain’s blood vessels. People with type 2 diabetes have a significantly elevated risk of developing Alzheimer’s, and even people without diabetes who have higher-than-normal blood sugar or insulin resistance show measurable changes in brain health over time.
Sleep and the Brain’s Waste Removal System
Your brain has a waste clearance network, sometimes called the glymphatic system, that flushes out metabolic byproducts including beta-amyloid and tau. This system works best during deep sleep, specifically the slow-wave phase (stage 3 NREM sleep). During deep sleep, the spaces between brain cells expand, allowing cerebrospinal fluid to flow more freely and carry waste away. Levels of a stimulating brain chemical called norepinephrine also drop, which relaxes the vessels the system depends on.
When deep sleep is disrupted, whether from sleep apnea, insomnia, shift work, or simply poor sleep habits, the brain’s ability to clear these proteins decreases. Over years and decades, this reduced clearance can contribute to the gradual accumulation of the very proteins that define Alzheimer’s. This is one reason sleep quality in midlife is increasingly recognized as a meaningful factor in long-term dementia risk.
Environmental Exposures
Long-term exposure to air pollution, particularly fine particulate matter and black carbon from vehicle exhaust and industrial sources, has been linked to increased dementia risk. The proposed mechanism involves several pathways: these tiny particles can trigger inflammatory responses in the brain, cause oxidative damage to DNA, disrupt the blood-brain barrier that normally protects neural tissue, and promote beta-amyloid deposition. A national cohort study published in the Proceedings of the National Academy of Sciences found that sustained exposure to fine particle pollution constituents was associated with higher rates of incident dementia, with black carbon showing particularly concerning neurotoxic effects.
Why “The Main Cause” Is the Wrong Frame
The honest answer to “what is the main cause” is that Alzheimer’s doesn’t work like an infection, where you can point to one pathogen. It works more like heart disease, where genetics load the gun and decades of overlapping factors pull the trigger. Amyloid and tau buildup are the defining features found in every Alzheimer’s brain, but the reasons those proteins accumulate vary from person to person, and the degree to which they explain symptoms varies too.
What this means practically is that the factors you can influence, quality sleep, cardiovascular and metabolic health, physical activity, reduced exposure to air pollution, matter alongside the genetic hand you were dealt. The disease typically develops over 15 to 20 years before symptoms appear, which means the window for these modifiable factors is long, and it starts well before old age.